{"id":447316,"title":"Quality Overall Summary - Chemical Entities Clinical Trial Application - Phase II (QOS-CE (CTA - Phase II)) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T14:10:07.816000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/templates/quality-overall-summary-chemical-entities-clinical-trial-application-phase-2.html?wbdisable=false","snippet":"Quality Overall Summary - Chemical Entities Clinical Trial Application - Phase II (QOS-CE (CTA - Phase II)) This HTML document is not a form. Its purpose is to display the information as found on the form for viewing purposes only. If you wish to submit a form, you must use only…","rawSnapshotUrl":"/api/snapshots/raw/447316","browseUrl":"https://replay.healtharchive.ca/job-6/20260103141007/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/templates/quality-overall-summary-chemical-entities-clinical-trial-application-phase-2.html?wbdisable=false#ha_snapshot=447316","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}